EUS-FNB without ROSE for Fine Needle Aspiration

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Fine Needle Aspiration+1 MoreEUS-FNA with ROSE - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a less expensive and simpler pancreatic cancer diagnosis procedure is just as good as the current standard.

Eligible Conditions
  • Fine Needle Aspiration
  • Pancreatic Mass

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 2 years

2 years
Number of passes
Percentage of histology cores obtained
Rate of technical failures
Specimen adequacy
The diagnostic accuracy of fine-needle biopsy (FNB) sampling without rapid onsite evaluation (ROSE) with the fine needle aspiration (FNA) with ROSE in pancreatic mass lesions

Trial Safety

Trial Design

2 Treatment Groups

EUS-FNB without ROSE
1 of 2
EUS-FNA with ROSE
1 of 2

Active Control

132 Total Participants · 2 Treatment Groups

Primary Treatment: EUS-FNB without ROSE · No Placebo Group · N/A

EUS-FNB without ROSE
DiagnosticTest
ActiveComparator Group · 1 Intervention: EUS-FNB without ROSE · Intervention Types: DiagnosticTest
EUS-FNA with ROSE
DiagnosticTest
ActiveComparator Group · 1 Intervention: EUS-FNA with ROSE · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,079 Previous Clinical Trials
31,020,199 Total Patients Enrolled
Mouen KhashabPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
20 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Maryland100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%